Frequently Asked Questions
What is the Medicare Part D $2,100 cap?
Medicare Part D has an annual out-of-pocket cap on covered prescription drug costs: $2,100 in 2026. The cap first took effect in 2025 at $2,000 and is adjusted each year for inflation. Once you have paid $2,100 in covered drug costs in a calendar year, you pay $0 for covered drugs for the rest of that year. This eliminates the old catastrophic coverage phase where seniors previously paid 5% of drug costs with no ceiling — leaving some seniors with drug bills of $10,000 or more annually.
Does the $2,100 cap include my premiums?
No — the $2,100 cap applies only to your out-of-pocket drug costs (deductibles, copays, and coinsurance for covered drugs). Monthly premiums do not count toward the $2,100 limit. Spending on drugs that are not on your plan's formulary also does not count toward the cap.
Who benefits most from the $2,100 drug cost cap?
Seniors who benefit most are those taking expensive specialty medications — cancer drugs, biologics for autoimmune conditions, multiple sclerosis treatments, and HIV medications that previously cost thousands of dollars monthly. 2024 (before reform), these patients could spend $10,000–$15,000 or more annually on drugs. With the cap, they pay a maximum of $2,100 regardless of drug cost.
What is the Medicare Prescription Payment Plan?
Since 2025, seniors can spread their $2,100 annual drug costs across the year in monthly installments rather than paying large amounts upfront in early months when deductibles are being met. This is called the Medicare Prescription Payment Plan (M3P). You must opt in the first time; starting in 2026 plans can automatically renew your participation each year, so confirm your status with your plan. Contact your Part D plan during AEP or at the start of the year to enroll.
Does the $2,100 cap apply to Medicare Advantage drug plans?
Yes — the $2,100 out-of-pocket cap applies to the drug coverage in all Medicare Part D plans, including both standalone Part D plans and the drug coverage embedded in Medicare Advantage plans. The cap is a federal requirement for all Medicare drug coverage, not just certain plan types.
The $2,100 annual cap on Medicare Part D drug costs is the most significant change to Medicare drug coverage since the Part D program was created in 2006. It eliminates the financial catastrophe that previously hit seniors taking expensive specialty medications — and changes the financial calculus for plan comparison during AEP. Here is exactly how it works.
Before vs After: The Change in Numbers
| Phase | 2024 (before reform) | 2026 |
|---|---|---|
| Annual deductible | Up to $545 | Up to $615 |
| Initial coverage | Copays/coinsurance | Copays/coinsurance |
| Coverage gap (donut hole) | Higher cost-sharing | ELIMINATED |
| Annual out-of-pocket cap | No cap — 5% forever | $2,100 CAP |
| After cap is reached | 5% of drug cost (no limit) | $0 — 100% covered |
Who Benefits Most
Seniors on Expensive Specialty Medications
The most dramatic change is for seniors taking specialty drugs for cancer, multiple sclerosis, rheumatoid arthritis, HIV, or other conditions where drugs cost $500–$5,000 per month. Previously, these seniors could reach $10,000 or more in annual drug costs with no ceiling. Under the cap, their maximum exposure is $2,100 — a reduction of thousands of dollars for many patients.
Seniors with Multiple Chronic Conditions
Seniors taking multiple brand-name medications for conditions like diabetes, heart disease, and COPD simultaneously often accumulated costs that exceeded the old catastrophic threshold. The $2,100 cap provides these patients with a predictable annual maximum they can budget for.
Insulin Users
Insulin has been capped at $35/month per product since 2023 — separate from the $2,100 cap. The two provisions work together: insulin costs contribute to the $2,100 annual accumulation at the $35 monthly rate, helping insulin-dependent seniors reach the cap faster.
The New Monthly Payment Option
The Medicare Prescription Payment Plan (M3P) began in 2025. Previously, seniors often paid large drug costs upfront in January and February as they met their deductible, then had lower costs later in the year. M3P allows you to smooth these costs into equal monthly payments across the year — eliminating the January cost spike.
To enroll in M3P: Contact your Part D plan during AEP (Oct 15–Dec 7) or at the beginning of the plan year. You must opt in the first time; for 2026, plans can renew your participation automatically each year, so confirm your status with your plan. Best for seniors taking expensive medications whose early-year costs are substantially higher than later in the year.
What This Means for AEP
The $2,100 cap changes how you should evaluate plans during AEP. Under the old system, seniors on expensive drugs needed to focus heavily on catastrophic phase protection. Under the new cap, the most important factors shift to: which plan has the lowest total cost to reach $2,100 (deductible structure + tier placement of your drugs), and the monthly premium. Use Medicare.gov Plan Finder and enter all your medications — the tool now calculates correctly for the 2026 cap structure.
- You pay $0 for covered drugs after reaching $2,100 in out-of-pocket costs — for the rest of the year
- Premiums do not count toward the $2,100 cap — only drug cost-sharing does
- Consider the monthly payment option (M3P) to avoid large early-year drug costs
- During AEP: compare plans based on total cost to reach the cap, not just premium
- Insulin is separately capped at $35/month — and counts toward your $2,100 accumulation